Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Testosterone therapy in women: its role in the management of hypoactive sexual desire disorder

International Journal of Impotence Research volume 19, pages 458–463 (2007)Cite this article

Abstract

Disorders of sexual dysfunction occur in nearly half of women during their life, and hypoactive sexual desire disorder accounts for most of those complaints. Although the relationship between low endogenous testosterone levels and sexual desire disorders in women has not been empirically established, clinical trials have shown that exogenous testosterone therapy improves arousability, sexual desire and fantasy, frequency of sexual activity and orgasm, and satisfaction and pleasure from the sexual act. Its therapeutic role in bone mineral density, fatigue, well-being and hot flashes requires more study before specific recommendations can be made. Potential adverse effects of testosterone therapy include hirsutism, acne and deepening of the voice along with changes in lipid profiles. While less well understood, concern after increased risks for breast cancer and cardiovascular events has been raised about this therapy. Testosterone therapy is available in various formulations; the most commonly used are oral and transdermal, including patches, gels, creams and ointments.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Laumann EO, Paik A, Rosen RC . Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537–544.

    Article  CAS  Google Scholar 

  2. Burger HG, Dudley EC, Cui J, Dennerstein J, Hopper JL . A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000; 85: 2832–2838.

    CAS  Google Scholar 

  3. Nathorst-Böös J, von Schoultz B . Psychological reactions and sexual life after hysterectomy with and without oophorectomy. Gynecol Obstet Invest 1992; 34: 97–101.

    Article  Google Scholar 

  4. Zussman L, Zussman S, Sunley R, Bjornson E . Sexual response after hysterectomy–oophorectomy: recent studies and reconsideration of psychogenesis. Am J Obstet Gynecol 1981; 140: 725–729.

    Article  CAS  Google Scholar 

  5. Bachmann G, Bancroft J, Braunstein G, Burger H, Davis S, Dennerstein L et al. Female androgen insufficiency: the Princeton Consensus Statement on Definition, Classification and Assessment. Fertil Steril 2002; 77: 660–665.

    Article  Google Scholar 

  6. Mushayandebvu T, Castracane VD, Gimpel T, Adel T, Santoro N . Evidence for diminished midcycle ovarian androgen production in older reproductive aged women. Fertil Steril 1996; 65: 721–723.

    Article  CAS  Google Scholar 

  7. Davis SR, McCloud P, Strauss BJ, Burger H . Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995; 21: 227–236.

    Article  CAS  Google Scholar 

  8. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000; 343: 682–688.

    Article  CAS  Google Scholar 

  9. Goldstat R, Briganti E, Tran J, Wolfe R, Davis SR . Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause 2003; 10: 390–398.

    Article  Google Scholar 

  10. Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S et al. Testosterone transdermal patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005; 90: 5226–5233.

    Article  CAS  Google Scholar 

  11. Raisz LG, Wiita B, Artis A, Bowen A, Schwartz S, Trahiotis M et al. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab 1996; 81: 37–43.

    CAS  PubMed  Google Scholar 

  12. Bachmann G . Androgen cotherapy in menopause: evolving benefits and challenges. Am J Obstet Gynecol 1999; 180: S308–S311.

    Article  CAS  Google Scholar 

  13. Dow MG, Hart DM, Forrest CA . Hormonal treatments of sexual unresponsiveness in postmenopausal women: a comparative study. Br J Obstet Gynaecol 1983; 90: 361–366.

    Article  CAS  Google Scholar 

  14. Regestein Q, Friebely J, Shifren J, Schiff I . Neuropsychological effects of methyltestosterone in women using menopausal hormone replacement. J Womens Health Gend Based Med 2001; 10: 671–676.

    Article  CAS  Google Scholar 

  15. Simon J, Klaiber E, Wiita B, Bowen A, Yang H-M . Differential effects of estrogen–androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion and endogenous androgen bioavailability in postmenopausal women. Menopause 1999; 6: 138–146.

    Article  CAS  Google Scholar 

  16. Montgomery J, Appleby L, Brincat M, Versi E, Tapp A, Fenwick PB et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1987; 1: 297–299.

    Article  CAS  Google Scholar 

  17. Floter A, Nathorst-Boos J, Carlstrom K, van Schoultz B . Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being. Climacteric 2002; 5: 357–365.

    Article  CAS  Google Scholar 

  18. Sherwin BB, Gelfand MM . Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol 1985; 151: 153–160.

    Article  CAS  Google Scholar 

  19. Barrett-Connor E, Young R, Notelovitz M, Sullivan J, Wiita B, Young HM et al. A two-year, double-blind comparison of estrogen–androgen and conjugated estrogens in surgically menopausal women: effects on bone mineral density, symptoms and lipid profiles. J Reprod Med 1999; 44: 1012–1020.

    CAS  PubMed  Google Scholar 

  20. Basaria S, Nguyen T, Rosenson RS, Dobs AS . Effect of methyl testosterone administration on plasma viscosity in postmenopausal women. Clin Endocrinol (Oxford) 2002; 57: 209–214.

    Article  CAS  Google Scholar 

  21. Dobs AS, Nguyen T, Pace C, Roberts CP . Differential effects of oral estrogen versus estrogen–androgen replacement therapy on body composition in postmenopausal women. J Clin Endocrinol Metab 2002; 87: 1509–1516.

    Article  CAS  Google Scholar 

  22. Farish E, Fletcher CD, Hart DM, Azzawi FA, Abdalla HI, Gray CE . The effects of hormone implants on serum lipoproteins and steroid hormones in bilaterally oophorectomised women. Acta Endocrinol (Copenh) 1984; 106: 116–120.

    Article  CAS  Google Scholar 

  23. Hickok LR, Toomey C, Speroff L . A comparison of esterified estrogens with and without methyltestosterone: effects on endometrial histology and serum lipoproteins in postmenopausal women. Obstet Gynecol 1993; 82: 919–924.

    CAS  PubMed  Google Scholar 

  24. Lobo RA, Rosen RC, Yang HM, Block B, Van Der Hoop RG . Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril 2003; 79: 1341–1352.

    Article  Google Scholar 

  25. Watts NB, Notelovitz M, Timmons MC, Addison WA, Wiita B, Downey LJ . Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol 1995; 85: 529–537.

    Article  CAS  Google Scholar 

  26. Dimitrakakis C, Jones RA, Liu A, Bondy CA . Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy. Menopause 2004; 11: 531–535.

    Article  Google Scholar 

  27. Somboonporn W, Davis S, for the National Health and Medical Research Council. Testosterone effects on the breast: Implications for testosterone therapy in women. Endocr Rev 2004; 25: 374–388.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obsterics and Gynecology, George Washington University, Washington, DC, USA

    R T Abdallah & J A Simon

Authors
  1. R T Abdallah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J A Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J A Simon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abdallah, R., Simon, J. Testosterone therapy in women: its role in the management of hypoactive sexual desire disorder. Int J Impot Res 19, 458–463 (2007). https://doi.org/10.1038/sj.ijir.3901558

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901558

Keywords

This article is cited by

Search

Advanced search

Quick links